Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
REGENXBIOregenxbio.com · Low evidenceREGENXBIO is a biotechnology company pioneering gene therapy through its NAV® Technology Platform, aiming to develop one-time treatments for patients with common and rare diseases. The company focuses on advancing gene therapy candidates for rare and retinal diseases to improve patient outcomes.
Parse Score